(CTN News) – In a significant development in the realm of oncology, the U.S. Food and Drug Administration (FDA) has bestowed full approval upon Pfizer’s groundbreaking drug, Tivdak, for the treatment of advanced cervical cancer. This announcement marks a pivotal milestone in the fight against a disease that affects thousands of women worldwide. Tivdak, an […]

The post FDA Grants Full Approval for Pfizer’s Tivdak in Treating Advanced Cervical Cancer appeared first on CTN News – Chiang Rai Times.

Go to Source
Author: Arsi Mughal